Duality Advisers’s Bio-Techne TECH Stock Holding History

Duality Advisers’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-56,338	Closed	-$3.83M	–	742
2023 Q3	$3.83M	Buy	56,338 +52,087	+1,225%	+$4.11M	0.46%	46
2023 Q2	$347K	Sell	4,251 -36,969	-90%	-$2.97M	0.04%	439
2023 Q1	$3.06M	Buy	41,220 +27,347	+197%	+$2.11M	0.35%	88
2022 Q4	$1.15M	Sell	13,873 -53,867	-80%	-$4.28M	0.13%	281
2022 Q3	$4.81M	Buy	67,740 +27,660	+69%	+$2.39M	0.52%	34
2022 Q2	$3.47M	Buy	+40,080	New	+$3.76M	0.34%	74

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Duality Advisers's TECH Position: Q4 2023 in Review

Duality Advisers sold out of Bio-Techne (TECH) in Q4 2023, closing a stake of 56,338 shares — an estimated $3.83M sold.

Duality Advisers first reported a position in TECH in Q2 2022 and held it in 6 quarters. The position peaked at $4.81M in Q3 2022. 531 funds tracked by Wall St. Rank hold TECH as of Q4 2023.

Duality Advisers reported no remaining Bio-Techne position as of Q4 2023 after selling out during the quarter.
Duality Advisers sold 56,338 Bio-Techne shares in Q4 2023, an estimated $3.83M.
Duality Advisers first reported a position in Bio-Techne in Q2 2022 and held it in 6 quarters.
Duality Advisers's Bio-Techne position peaked at $4.81M in Q3 2022.
531 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2023.

Based on Duality Advisers's 13F filing for Q4 2023, filed 1 Feb 2024.